Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,741 -9.00 (-0.33%)
As of 03/28/2025 12:41 PM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,715
2,746
50-Day Range
2,590
3,218
52-Week Range
2,552
4,800
Volume
3,845 shs
Average Volume
5,416 shs
Market Capitalization
£143.53 million
P/E Ratio
17.73
Dividend Yield
5.76%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Remove Ads
Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Stock News Headlines

3 top AIM stocks to consider buying before they recover
Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP stock has decreased by 15.4% and is now trading at GBX 2,741.
View the best growth stocks for 2025 here
.

Bioventix PLC (LON:BVXP) announced its quarterly earnings results on Monday, October, 28th. The biotechnology company reported $155.12 earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
10/28/2024
Today
3/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
17.73
Forward P/E Ratio
16.48
P/E Growth
N/A
Net Income
£8.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.65 million
Cash Flow
GBX 88.74 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
11.92

Miscellaneous

Free Float
N/A
Market Cap
£143.53 million
Optionable
Not Optionable
Beta
0.35
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (LON:BVXP) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners